<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03202823</url>
  </required_header>
  <id_info>
    <org_study_id>MENEGAUT 2016</org_study_id>
    <nct_id>NCT03202823</nct_id>
  </id_info>
  <brief_title>Arachidonic Acid Metabolism in Carotid Stenosis Plaque in Diabetic Patients</brief_title>
  <acronym>MASCADI</acronym>
  <official_title>Arachidonic Acid Metabolism in Carotid Stenosis Plaque in Diabetic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Diabetes is associated with an increased risk of cardiovascular complications, as a&#xD;
      reflection of the chronic inflammatory status. Monocytes-macrophages in diabetic subjects&#xD;
      present impaired arachidonic acid metabolism. Moreover, atheromatous plaques in diabetic&#xD;
      subjects seem to be significantly enriched in 2-AA-LPC&#xD;
      (2-arachidonoyl-lysophosphatidylcholine) and are more inflammatory and more likely to rupture&#xD;
      than are plaques in non-diabetic subjects. We therefore hypothesize that this vulnerability&#xD;
      of atheromatous plaques in diabetic subjects could be explained by impaired 2-AA-LPC&#xD;
      metabolism within the plaque.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 13, 2017</start_date>
  <completion_date type="Actual">December 11, 2020</completion_date>
  <primary_completion_date type="Actual">December 11, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in arachidonic acid metabolism of atheromatous plaques from diabetic versus non-diabetic subjects</measure>
    <time_frame>Baseline</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">204</enrollment>
  <condition>Carotid Stenosis</condition>
  <arm_group>
    <arm_group_label>Diabetics</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-diabetics</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>blood samples</intervention_name>
    <description>3 tubes (5 ml volume) collected during surgery</description>
    <arm_group_label>Diabetics</arm_group_label>
    <arm_group_label>Non-diabetics</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>recover samples of atheromatous plaque</intervention_name>
    <description>a carotid sample collected during surgery</description>
    <arm_group_label>Diabetics</arm_group_label>
    <arm_group_label>Non-diabetics</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Diabetic and non-diabetic patients with carotid stenosis who undergo surgery&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients who have provided explicit consent&#xD;
&#xD;
          -  Patients older than 18 years&#xD;
&#xD;
          -  Patients about to undergo surgery for carotid stenosis&#xD;
&#xD;
          -  Haemoglobin â‰¥ 7g/dl at the time the sample is taken&#xD;
&#xD;
          -  Respect the maximum volume of blood taken (treatment + research) in 30 days&#xD;
&#xD;
        SPECIFIC TO DIABETICS&#xD;
&#xD;
        - Patients with type 1 or 2 diabetes diagnosed more than 6 months earlier&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients under guardianship&#xD;
&#xD;
          -  Patients without health insurance cover&#xD;
&#xD;
          -  Pregnant or breast-feeding women&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Chu Dijon Bourgogne</name>
      <address>
        <city>Dijon</city>
        <zip>21000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>June 21, 2017</study_first_submitted>
  <study_first_submitted_qc>June 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 29, 2017</study_first_posted>
  <last_update_submitted>January 25, 2021</last_update_submitted>
  <last_update_submitted_qc>January 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carotid Stenosis</mesh_term>
    <mesh_term>Constriction, Pathologic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

